stockportfolio.pro
Stocks / BBIO vs THC
BBIO vs THC
BridgeBio Pharma, Inc. and Tenet Healthcare Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
THC is the larger company ($14.1B vs $13.3B). On the fundamentals, BBIO grows revenue faster (127.4% vs 3.9%); THC earns a higher net margin (6.6% vs -144.4%); BBIO has the stronger return on equity (34.7% vs 33.3%). Full numbers below — the stronger figure on each row is in green.
| BridgeBio Pharma, Inc. (BBIO) | Tenet Healthcare Corporation (THC) | |
|---|---|---|
| Market cap | $13.3B | $14.1B |
| Revenue (latest FY) | $502.08M | $21.31B |
| Net income (latest FY) | $-724.93M | $1.41B |
| Revenue growth (5y CAGR) | 127.4% | 3.9% |
| Net margin | -144.4% | 6.6% |
| Return on equity | 34.7% | 33.3% |
| P/E ratio | — | 8.5 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 9 |
| Positive free cash flow | No | Yes |
Compare with another company:
See the full BBIO vs THC breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open BBIO's full financials → Open THC's full financials →More comparisons
Frequently asked questions
Which is bigger, BBIO or THC?
Tenet Healthcare Corporation is larger by market capitalization — $14.1B versus $13.3B.
Which grows faster, BBIO or THC?
Over the last five fiscal years, BridgeBio Pharma, Inc. grew revenue faster — 127.4%/yr versus 3.9%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.